Clinical Trials Logo

Superficial Vein Thrombosis clinical trials

View clinical trials related to Superficial Vein Thrombosis.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT05001776 Completed - Clinical trials for Superficial Vein Thrombosis

Endovenous Laser Ablation in Acute Thrombophlebitis of the Varicose Great Saphenous Vein

Start date: August 16, 2021
Phase: Phase 4
Study type: Interventional

Рrospective single-centre randomized open-label study for comparison three modes of treatment for thrombosis of varicose great saphena vein - standard medical with fondaparinux sodium for 45 days, endovenous laser ablation close to the saphenofemoral junction with a 7-day course of anticoagulation and endovenous laser ablation close to the saphenofemoral junction without the use of anticoagulants.

NCT ID: NCT02699151 Completed - Clinical trials for Superficial Vein Thrombosis

INvestigating SIGnificant Health TrendS in the Management of Superficial Vein Thrombosis

INSIGHTS-SVT
Start date: April 14, 2016
Phase:
Study type: Observational

Superficial vein thrombosis (SVT) and venous thromboembolism (VTE) are related entities. Only in the last years a series of observational studies mainly conducted in France could show that ´isolated SVT´ (without concomitant deep vein thrombosis and/or pulmonary embolism) is in fact not a benign and spontaneously healing disease but bears a potential for severe thromboembolic complications once not treated adequately. INSIGHTS-SVT study aims at collecting representative data on the current management and outcomes of SVT in Germany under real-life conditions. It will document the implementation of the recently issued national SVT guidelines issued by the Society for Angiology (DGA) and the Society for Phlebology (DGP).

NCT ID: NCT01501175 Completed - Clinical trials for Superficial Vein Thrombosis

Incidence of Superficial Vein Thrombosis

STEPH
Start date: November 2011
Phase: N/A
Study type: Observational

To date, the investigators still do not know the annual incidence of Superficial Vein Thrombosis in the legs, although the investigators do know that this pathology is frequent and the investigators can assume its incidence is greater than Deep Vein Thrombosis which is of 1 to 2 cases per year per 1,000 inhabitants. Furthermore, the high percentage of SVT with concomitant DVT and Pulmonary Embolism only concerns patients seen in vascular medicine, so it is important to re-evaluate this rate on an unselected population from general practice.

NCT ID: NCT01499953 Completed - Clinical trials for Superficial Vein Thrombosis

Superficial Vein Thrombosis (SVT) Treated With Rivaroxaban Versus Fondaparinux

Start date: April 2012
Phase: Phase 3
Study type: Interventional

The purpose of this study is to evaluate the efficacy and safety of rivaroxaban versus fondaparinux in the treatment of superficial vein thrombosis (SVT).